Konstantin Konstantinov is of REPLIGEN CORP. Currently has a direct ownership of 1,921 shares of RGEN, which is worth approximately $266,269. The most recent transaction as insider was on May 16, 2024, when has been sold 701 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.92K
0% 3M change
57.46% 12M change
Total Value Held $266,269

Konstantin Konstantinov Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2024
BUY
Grant, award, or other acquisition
-
701 Added 26.74%
1,921 Common Stock
May 18 2023
BUY
Grant, award, or other acquisition
-
686 Added 35.99%
1,220 Common Stock
May 26 2022
BUY
Grant, award, or other acquisition
-
534 Added 50.0%
534 Common Stock

Also insider at

CDAK
Codiak BioSciences, Inc. Healthcare
KK

Konstantin Konstantinov

Cambridge, MA

Track Institutional and Insider Activities on RGEN

Follow REPLIGEN CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN